Global vaccines producers losing market share in Russia

16 April 2019
russia_lake_stock_large

Global vaccines producers are losing their positions in the Russian market, due to the ever growing competition with local producers, which receive support from the state, according to recent statements of producers, reports The Pharma Letter’s local correspondent.

This is despite the fact that vaccination coverage in Russia, particularly against flu, has significantly increased in recent years.

This is confirmed by statistics from the Russian Ministry of Health, according to which the vaccination coverage against flu in Russia over the last 11 years has grown by 2.4 times from 28 million people in 2006 to up to 67.4 million people vaccinated in 2017.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical